UPDATE 1-U.S. drugmaker Pfizer pauses new studies due to coronavirus pandemic
March 25, 2020 at 13:28 PM EDT
Pfizer Inc said on Wednesday it was delaying patient recruitment in new and ongoing global trials for three weeks due to the coronavirus outbreak, as drugmakers look to ease the burden on healthcare facilities and on doctors treating coronavirus patients.
